Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Additions to Study Design

<< Previous

Bullboard Posts

Next >>

Comment by Eoganachton Mar 23, 2024 11:48am

247 Views

Post# 35948747

RE:RE:RE:RE:RE:RE:Additions to Study Design

Mikee3003 - as a secret agent for Theralase management, don't you think I'd know better than you?

But maybe I'm just another poor schnook long who can't resist speculating about his Hail Mary pass retirement funding longshot.

Eh?

Mikee3003 wrote: Eoganacht - I very much doubt a deal is in place dependent on getting BTD. If this was the case TLT would be handcufed with a LOI and I would certainly expect that a if there was a signed LOI it would be considered material information and a news release would need to be issued.

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec